40
Participants
Start Date
October 31, 2001
Primary Completion Date
September 30, 2005
Study Completion Date
April 30, 2007
Herceptin
IV
Baylor Breast Center, Houston
Collaborators (1)
Genentech, Inc.
INDUSTRY
Mothaffar Rimawi
OTHER